medigraphic.com
SPANISH

Gaceta Médica de México

ISSN 0016-3813 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2017, Number 4

<< Back Next >>

Gac Med Mex 2017; 153 (4)

Trombosis primaria de la descendente anterior en un paciente con síndrome de anticuerpos antifosfolípidos

Acuña-Valerio J, Peña-Duque MA, Contreras-Villaseñor Á
Full text How to cite this article

Language: Spanish
References: 12
Page: 526-530
PDF size: 226.51 Kb.


Key words:

Antiphospholipid antibody syndrome, Antiphospholipid antibodies, Coronary thrombosis, Acute myocardial infarction, Non-reflow phenomenon.

ABSTRACT

Antiphospholipid antibody syndrome is a heterogeneous clinical and biochemical entity. We present the case of a young male with history of venous thromboembolism. This time he presents because of chest ischemic pain associated with ST segment elevation. He was taken to the cath lab to perform a primary percutaneous coronary intervention and a total occlusion of the left anterior descending artery was noted. Successful thrombus aspiration was performed. No stent was deployed. He was taken to the cath lab for a second look angiography and no atherosclerotic lesions were observed, which was confirmed by intravascular ultrasound.


REFERENCES

  1. Miranda CH, Gali LG, Marin-Neto JA, et al. Coronary thrombosis as the first complication of antiphospholipid syndrome. Arq Bras Cardiol. 2012;98:e66-9.

  2. Asherson RA, Cervera R. Antiphospholipid antibodies and the heart; lessons and pitfalls for the cardiologist. Circulation. 1991;84:920-3.

  3. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295-306.

  4. Cervera R, Piette J, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019-27.

  5. Long BR, Leya F. The role of antiphospholipid syndrome in cardiovascular disease. Hematol Oncol Clin N Am. 2008;22:79-94.

  6. Vianna JL, Khamashta M, Ordi-Ros J, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med. 1994;96:3-9.

  7. Sacré K, Brihaye B, Hyafil F, et al. Asymptomatic myocardial ischemic disease in antiphospholipid syndrome. Arthritis Rheum. 2010;62:2093-100.

  8. Monteiro AV, Branco LM, de Sousa L, et al. Antiphospholipid syndrome: a recurrent cardiac thromboembolic insult in spite of optimal anticoagulation. Reumatol Clin. 2015;11:177-8.

  9. Santos JL, Cruz I, Herrero FM, et al. Trombosis coronaria recurrente, síndrome antifosfolipídico primario, factor V Leiden y virus de la inmunodeficiencia humana. Rev Esp Cardiol. 2004;57:997-9.

  10. Middlebrooks EH, Panda M. Multiple recurrent stent thrombosis in a patient with coexisting clopidogrel resistance and increased anticardiolipin antibodies: a case report. Case Rep Med. 2010;2010:1-5.

  11. Toffon A, Piovesan R, Minniti CF, et al. Lower limb ischemia: aortoiliac thrombosis related to antiphospholipid syndrome (APS) − case report and review of literature. Case Rep Surg. 2013;2013:536971.

  12. Namazi MH, Kaheshi I, Serati AR, et al. Resistant hypertension due to unilateral renal artery occlusion as the first presentation of antiphospholipid syndrome. Cardiovasc Revasc Med. 2015;16:190-1.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Gac Med Mex. 2017;153